The current 100 ppb short-term National Ambient Air Quality Standard for NO 2 , and EPA's determination of a causal association for respiratory effects, are based in part on controlled human exposure studies evaluating airway hyper-responsiveness (AHR). A meta-analysis by Goodman et al. (2009) found increased AHR at 100 ppb NO 2 but no clear concentration-response relationship up to 600 ppb, and an overall lack of an AHR effect for studies involving exercise or exposure to allergens. Several factors have been suggested to explain why effects on AHR are observed while people are at rest, but not during exercise or after exposure to allergens. These include an exercise-induced refractory period; partial reversal of bronchospasm from use of forced expiration maneuvers; and greater airway responsiveness of participants exposed to NO 2 at rest. We reviewed the scientific evidence to determine whether there is biological support for these factors and found that none sufficiently explained the lack of an effect during exercise or after exposure to allergens. In the absence of either a consistent concentration-response or a plausible explanation for the paradoxical AHR findings, the biological significance of these findings is uncertain and provides equivocal support for NO 2 as a causal factor of AHR at these exposure levels.
Introduction
The current 1-h primary National Ambient Air Quality Standard (NAAQS) for nitrogen dioxide (NO 2 )e100 parts per billion (ppb)eis partly based on the results of controlled human exposure studies that evaluated airway hyper-responsiveness (AHR). The United States Environmental Protection Agency's (EPA's) recent Integrated Science Assessment (ISA) for NO 2 also partly relied on the results of these studies for its determination that there is a causal association between short-term NO 2 exposure and respiratory effects (US EPA, 2016) . These controlled exposure studies evaluated the ability of NO 2 to enhance bronchoconstriction in response to either a nonspecific airway challenge (e.g., a pharmacological agent such as carbachol, methacholine, or histamine; sulfur dioxide [SO 2 ]; or cold air) or to a specific airway challenge (i.e., an allergen).
A meta-analysis by Goodman et al. (2009) found that although AHR was increased at 100 ppb NO 2 , there was no clear concentration-response up to 600 ppb, as would be expected if NO 2 were causally associated with AHR. Further, increased AHR following NO 2 exposure was observed in studies in which participants were exposed to NO 2 while at rest but not, paradoxically, in studies in which participants were exposed to NO 2 while exercising. Moreover, increased AHR following NO 2 exposure was generally not observed in studies involving specific airway challenges and studies in which study participants were exposed to NO 2 in a chamber.
It has been hypothesized that various methodological factors related to study design and AHR assessment limited the ability to detect an effect of NO 2 on AHR (Brown, 2015) . Below, we explore these factors, specifically in terms of whether they provide plausible explanations regarding findings from studies involving exposure at rest vs. exposure while exercising, and from studies involving exposure to specific airway challenges. For this analysis, we relied on the studies included in the Goodman et al. (2009) meta-analysis, as well as an additional study by Riedl et al. (2012) that was reviewed by US EPA in its most recent ISA (US EPA, 2016) and by Brown (2015) . Table 1 summarizes 35 exposure scenarios from 26 studies evaluated in this current analysis.
Refractory period following exercise
In contrast to controlled human exposure studies of ozone and Goodman et al. (2009) reported that NO 2 did not have a significant effect overall on AHR for studies in which participants were exposed to NO 2 while exercising. The paradoxical lack of a significant effect on AHR for studies in which participants were exposed to NO 2 while exercising (vs. at rest) has been attributed to a potential refractory period following exercise (e.g., Brown, 2015; Bylin, 1993; Folinsbee, 1992) . A refractory period following exercise, during which bronchoconstriction to a subsequent bout of exercise is diminished, is an established phenomenon that is likely due to release of inhibitory prostaglandins (O'Byrne et al., 2009 ). It is not clear, however, whether the refractory effect extends to challenges other than exercise. As discussed by McFadden and Gilbert (1994) , individuals may be refractory to exercise-induced bronchoconstriction but still maintain responsiveness to other airway challenges. This has been demonstrated in several other studies, in which individuals maintained post-exercise sensitivity to non-specific airway challenges (such as histamine or methacholine) despite being refractory to exercise-induced bronchoconstriction following repeated bouts of exercise (e.g., Boulet et al., 1987; Hahn et al., 1984; Hamielec et al., 1988; Magnussen et al., 1986) . Although Magnussen et al. (1986) found that a diminished airway response to exercise correlated with a diminished response to a methacholine challenge, Magnussen et al. (1986) also reported that the methacholine provocative doses (PDs) that caused a 50% decrease in specific airway conductance before and after exercise were not significantly different.
A study by Jorres and Magnussen (1990) , which found statistically significant increases in AHR to SO 2 following a 30-min exposure to 250 ppb NO 2 at rest, and a study by Rubinstein et al. (1990) , which found no change in responsiveness to SO 2 following 30-min exposures to 300 ppb NO 2 with 20 minutes of exercise, have been noted as providing support for the hypothesis that an exerciseinduced refractory period diminishes the response to an airway challenge (Brown, 2015) . However, this paradoxical pattern of an AHR effect when study participants were exposed at rest but not while exercising may be a function of the study design. For example, Jorres and Magnussen (1990) exposed study participants via a mouthpiece, while Rubinstein et al. (1990) used an exposure chamber. As discussed by Paek and McCool (1992) , relative to normal oronasal breathing, breathing via a mouthpiece increases the minute ventilation, the tidal volume, and the inspiration time, thus increasing both the amount of NO 2 delivered to the lower airways and the time that NO 2 is in contact with the lower airways. Although the overall effect of increased delivery and contact time is not clear, it is likely that airway effects would be enhanced by breathing via a mouthpiece relative to normal oronasal breathing. Hence, the significant effect observed by Jorres and Magnussen (1990) could be related, at least in part, to the exposure method used in this study rather than the hypothesized lack of an exerciseinduced refractory period.
In further exploring the concept of an exercise-induced refractory period, Inman et al. (1990) and Freedman et al. (1988) have been cited to support the hypothesis that exercise may diminish the responsiveness to a bronchial challenge agent (Brown, 2015) . These studies, however, raise an interesting question concerning the impact and importance of when the challenge agent is administered relative to exercise (i.e., before, during, or after). Inman et al. (1990) found that the protection afforded by exercise (in terms of reduced bronchoconstriction) increased with the level of exercise, as indicated by a concomitant increase in methacholine concentration required to reduce the forced expiratory volume in 1 second (FEV 1 ) by 20% (i.e., the provocation concentration causing a 20% decrease in FEV 1 , or PC 20 ). Freedman et al. (1988) found that methacholine-induced bronchoconstriction was reversed more rapidly following periods of exercise or hyperventilation than following periods of rest. However, published NO 2 /AHR studies in which the challenge agent was administered after a period of exercise are not analogous to the studies by Inman et al. (1990) and Freedman et al. (1988) in which methacholine was administered during or before exercise, respectively. Thus, results from Inman et al. (1990) and Freedman et al. (1988) may not apply to the NO 2 /AHR studies. This is further supported by studies in which post-exercise sensitivity to non-specific airway challenges was maintained when the bronchial challenge agent was administered after a period of exercise (e.g., Boulet et al., 1987; Hahn et al., 1984; Hamielec et al., 1988; Magnussen et al., 1986) , which is analogous to the study design used for the NO 2 /AHR studies.
In addition to the aforementioned studies, results from several of the NO 2 AHR studies do not provide evidence of a refractory period for AHR following exercise. Rather, the PD that caused a 100% increase in specific airway resistance (PD 100 ) when measured without prior exercise was either comparable to or greater than that measured following exposure to filtered air, with exercise. In the study by Jorres and Magnussen (1991) , the PD 100 (geometric mean ± standard deviation, as mg/mL methacholine) measured without prior exercise was 0.46 ± 1.47, vs. 0.41 ± 1.62 measured following exposure to filtered air, with exercise. In the study by Strand et al. (1996) , the PD 100 (average ± standard deviation, as mg histamine) at study inclusion (without prior exercise) was 251 ± 192 vs. 296 ± 331 vs. following exposure to filtered air, with exercise. In the study by Roger et al. (1990) , the PD 100 (average ± standard error of the mean, as cumulative inhalation units) was significantly greater (p < 0.05) when measured at study inclusion. Without prior exercise (5.1 ± 1.1) than when measured following exposure to filtered air, with exercise (3.3 ± 0.7).
Even assuming that some individuals may experience an exercise-induced refractory period to a subsequent airway challenge, and that exercise intensity in the NO 2 AHR studies was sufficient to elicit exercise-induced bronchoconstriction, the refractory effect would not necessarily abolish the AHR effect altogether, but rather would increase the threshold for the effect (e.g., Inman et al., 1990) . This means that any effect of exercise would occur on both NO 2 and filtered air exposure days. If AHR in response to an airway challenge is observed following inhalation of filtered air, then one should observe a more pronounced effect following NO 2 exposure if NO 2 were associated with AHR. In fact, AHR (as evidenced by either decreased FEV 1 or airway conductance in response to an airway challenge, or a decrease in the airway challenge doubling dose) was observed in six NO 2 studies that provided pulmonary function data both before and after administration of the airway challenge (e.g., Avol et al., 1988 Avol et al., , 1989 Bauer et al., 1986; Morrow and Utell, 1989; Roger et al., 1990; Witten et al., 2005) . Only one of these six studies (Bauer et al., 1986 ) observed a significant difference in AHR following exposure to filtered air vs. NO 2 . Overall, the available evidence does not indicate that the lack of an NO 2 effect on AHR for studies in which individuals were exposed to NO 2 while exercising can be explained, at least in part, by an exercise-induced refractory period.
3. Use of deep inspiration to deliver non-specific challenge agents and assess AHR Use of deep inspiration to total lung capacity (TLC) has also been hypothesized as a factor that may have contributed to the lack of a significant NO 2 effect on AHR for studies in which participants were exposed to NO 2 while exercising, or for studies evaluating specific airway challenges (Brown, 2015) . Specifically, airway challenge methods in which delivery of a non-specific airway challenge involves deep inspiration to TLC can result in bronchoprotection for some individuals with asthma, and may thus yield higher provocative doses than methods involving submaximal inhalations or tidal breathing (e.g., Cockcroft and Davis, 2006; Cockcroft et al., 2005) . In addition, studies have shown that a deep inspiration, as is undertaken immediately prior to measuring forced vital capacity (FVC) and FEV 1 (i.e., an FVC maneuver), might cause a partial reversal of bronchospasm in response to an airway challenge (as indicated by a reduction in FEV 1 ) without a corresponding decrease in airway resistance (e.g., Beaupre and Orehek, 1982; Jackson et al., 2004; Orehek et al., 1981a If use of deep inspiration to deliver non-specific airway challenges resulted in bronchoprotection for some of the study participants, then studies that delivered airway challenges using deep inspiration should have been less likely to observe increased AHR. To evaluate whether this is the case, we meta-analyzed studies (using STATA 14) to compare the pooled standardized mean differences (SMDs) in AHR across different approaches used to deliver non-specific airway challenges (i.e., deep inspiration vs. tidal breathing or submaximal inhalation) using random-effects models. As shown in Table 2 , the AHR response to NO 2 did not differ significantly between studies that used deep inspiration vs. tidal breathing or submaximal inhalation (pooled SMD ¼ 0.239 vs. 0.253; p for between-group heterogeneity ¼ 0.943). Thus, it does not appear that studies that delivered non-specific airway challenges were less likely to observe increased AHR.
Using a similar approach, we also conducted meta-analyses to evaluate whether use of FVC maneuvers (i.e., those that assessed AHR using FEV 1 ) reduced the likelihood of observing increased AHR for studies in which participants were exposed to NO 2 while exercising (listed in Table 3 ). If it is true that the lack of a significant NO 2 effect on AHR is due to the use of FVC maneuvers to evaluate AHR, we would expect that the use of FVC maneuvers would reduce the likelihood of observing increased AHR. Considering all studies for which participants were exposed to NO 2 while exercising, the AHR response did not differ significantly between studies that assessed AHR using FVC maneuvers vs. those using airway resistance or conductance (pooled SMD ¼ 0.017 vs. 0.033; p for between-group heterogeneity ¼ 0.967). When we excluded the exposure scenario from the study by Riedl et al. (2012) involving exposure to cat allergen, for which AHR was significantly decreased, the difference in response between studies that assessed AHR using FVC maneuvers vs. airway resistance or conductance remained not significant (p for between-group heterogeneity ¼ 0.262), but AHR was significantly increased for studies that assessed AHR using FVC maneuvers (pooled Table 2 AHR as a function of airway challenge delivery method (deep inspiration vs. tidal breathing/submaximal inhalation) for non-specific airway challenges. a The SMDs and their 95% CIs were calculated using the study-specific data presented in Table 1 , with the function "metan" in STATA 14. b The pooled SMDs were calculated using random-effect meta-analyses, with the function "metan" in STATA 14. c The p-value for between-group heterogeneity was calculated using meta-regression, with the function "metareg" in STATA 14.
SMD ¼ 0.23, 95% CI: 0.034e0.426). Thus, although it may be biologically plausible that the use of FVC maneuvers could mask an AHR effect, results from the NO 2 /AHR studies for which study participants were exposed to NO 2 while excursing do not indicate that use of FVC maneuvers biased studies towards not finding an AHR effect. Only two studies that evaluated specific airway challenges assessed AHR using airway resistance or conductance (Ahmed et al., 1983a , as cited in Folinsbee, 1992 Strand et al., 1997 ), thus it is not possible to assess whether studies that assessed AHR using airway resistance or conductance were more likely to observe increased AHR than studies that assessed AHR using FVC maneuvers. However, based on findings for studies involving exercise, it does not appear that use of FVC maneuvers biased studies towards not observing increased AHR.
Subject inclusion/exclusion criteria
Another hypothesized explanation for the lack of an NO 2 effect on AHR in studies involving exercise is that participants with more responsive airways may have been excluded, thus biasing results from these studies towards the null (Brown, 2015) .
To assess whether participants differed with respect to airway responsiveness, we compared baseline airway function based on individuals' percentage of the predicted FEV 1 (% predicted FEV 1 ), as well as the FEV 1 /FVC ratio, both of which are used to classify asthma severity. For example, according to the National Asthma Education and Prevention Program, asthma is classified as mild, moderate, or severe if the % predicted FEV 1 is >80%, 60e80%, or <60%, respectively; or if the FEV 1 /FVC ratio is >80%, 75e80%, or <75%, respectively (NIH, 2012) . If the hypothesis that individuals with more responsive airways may have been excluded from studies involving exercise is correct, we would expect both % predicted FEV 1 at baseline and the FEV 1 /FVC ratio to be lower for studies in which participants were exposed to NO 2 while at rest. Percent predicted FEV 1 and FEV 1 /FVC ratios are provided in Tables 4a and 4b , for subjects exposed to NO 2 while at rest or while exercising, respectively. For % predicted FEV 1 , we based our analysis on % predicted FEV 1 , if provided in a study, or calculated it if not, using predicted values from Hankinson et al. (1999) and the study participants' sex, age, and height. Eight studies in which participants were exposed at rest and five studies in which participants were exposed while exercising did not provide either % predicted FEV 1 or age and height information. Based on average % predicted FEV 1 for each study (when available), we found that asthma status was mild and comparable for studies in which participants were exposed to NO 2 at rest (% predicted FEV 1 weighted average of 101 ± 4) and while exercising (% predicted FEV 1 weighted average of 87 ± 3). Only two studies in which participants were exposed to NO 2 at rest provided FEV 1 /FVC ratios, of 71% (Jorres and Magnussen, 1990 ) and 72% (Mohsenin, 1987) . These ratios are comparable to the weighted average ratio of 74 ± 5%, for studies in which participants were exposed to NO 2 while exercising.
We also considered asthma severity, which is associated with non-specific airway responsiveness (e.g., Grootendorst and Rabe, 2004) . As shown in Table 4a , the asthma severity of participants (as classified by the study authors) was mild in all but three studies involving exposures at rest, for which information regarding participants' asthma severity was not provided. Among studies in which participants were exposed while exercising (Table 4b) , participants' asthma status was mild in six studies, asymptomatic in two studies, mild to moderate in one study, and moderate to severe b AHR assessed using specific airway resistance (sRAW) or specific airway conductance (sGAW). c The SMDs and their 95% CIs were calculated using the study-specific data presented in Table 1 , with the function "metan" in STATA 14. d AHR assessed using PD10RHE (respiratory heat exchange causing a 10% decrease in FEV 1 ). e Study participants challenged with methacholine. f Study participants challenged with cat allergen. g The pooled SMDs were calculated using random-effect meta-analyses, with the function "metan" in STATA 14. h The p-value for between-group heterogeneity was calculated using meta-regression, with the function "metareg" in STATA 14.
in one study. Information regarding asthma severity was not provided in the remaining two studies in which participants were exposed while exercising. Thus, based on asthma status as classified by the study authors, asthma severity, and by extension airway responsiveness, was comparable for studies in which participants were exposed to NO 2 while at rest vs. while exercising. Although asthma severity was comparable for studies in which participants were exposed to NO 2 while at rest vs. while exercising, AHR could not be assessed for half of the participants in the study by Morrow and Utell (1989) , which the authors presumed is due to preexisting exercise-induced bronchoconstriction. Thus, individuals with more severe asthma may not have been assessed in the study by Morrow and Utell (1989) .
With the exception of the study by Morrow and Utell (1989) , there is no indication that participants in studies involving exposure to NO 2 while at rest were more responsive to airway challenges. Hence, the lack of a significant NO 2 effect on AHR for studies in which participants were exposed to NO 2 while exercising does not seem to be explained by preferential inclusion of participants with less responsive airways in these studies.
Medication usage
As discussed by Brown (2015) , insufficient withholding times for asthma medication may have reduced airway responsiveness, and thus reduced the ability of studies to detect an effect of NO 2 exposure on AHR. We thus assessed whether the lack of an NO 2 effect on AHR in studies involving exercise might be related to shorter medication withholding time prior to the participants' exposure, which may have masked or blunted the effect of NO 2 .
To assess whether differences in medication withholding time prevented the observation of NO 2 -induced AHR in studies involving exercise, we assigned studies as having a sufficient, borderline, or insufficient withholding time, according to the type of medication used by the study participants. Adequate information was provided so that we could assign studies according to withholding time for 14 studies in which participants were exposed to NO 2 while at rest and 14 studies in which participants were exposed to NO 2 while exercising. Based on duration of action, we considered withholding times of 6 and 24 hours to be sufficient for short-and long-acting b2-agonists, respectively (Cazzola et al., 2012; Currie et al., 2013; Palmqvist et al., 1997; Tamm et al., 2012) , and a withholding time Table 4a Baseline lung function, asthma status, medication status, and medication withholding time for studies in which participants were exposed to NO 2 at rest. Hankinson et al., 1999) . e Asthma status considered "slight to mild".
of 48 hours to be sufficient for corticosteroids (Tamm et al., 2012) . We considered withholding times to be borderline for one study that withheld b2-agonists for 6 hours without specifying whether the b2-agonists were short-or long-acting, and for seven studies that withheld b2-agonists for 8 hours without specifying whether the b2-agonists were short-or long-acting. Withholding times were also considered to be borderline for two studies that withheld corticosteroids with relatively short half-lives (approximately 3 hours) on the day of exposure. If the lack of an NO 2 effect on AHR in studies involving exercise is related to shorter medication withholding times, then we would expect that withholding times are more likely insufficient or borderline for studies in which participants were exposed to NO 2 while exercising. Although the numbers in each category are small, and there are a few for which information is missing, as shown in Table 5 , the distribution of studies according to medication withholding time was similar (p value for homogeneity ¼ 1.0) for studies in which participants were exposed to NO 2 at rest vs. while exercising. This cursory analysis suggests that shorter or insufficient medication withholding times did not contribute to the difference in NO 2 -induced AHR for studies in which participants were exposed to NO 2 while exercising vs. at while at rest. Brown (2015) also indicated that use of dietary supplements such as vitamin C, which may prevent NO 2 -induced AHR, may have been more prevalent in studies involving exercise. However, information on vitamin C intake is not provided for the NO 2 /AHR studies, and thus it is not possible to assess the extent to which vitamin C intake differed between studies in which participants were exposed to NO 2 while exercising vs. at rest.
Table 4b
Baseline lung function, asthma status, medication status, and medication withholding time for studies in which participants were exposed to NO 2 while exercising.
Study
N Baseline % predicted FEV 1 (Av.)
% FEV 1 /FVC (Av.)
Conclusions
It has been hypothesized that several factors may have biased studies towards not observing an NO 2 effect on AHR when participants were exposed to NO 2 while exercising and when participants were exposed to specific airway challenges (Brown, 2015) . These hypotheses include the existence of a refractory period following exercise, the use of FVC maneuvers, and the exclusion of participants with greater airway responsiveness from studies involving exercise. Use of asthma medication or dietary supplements has also been hypothesized as a factor that could attenuate NO 2 's AHR effect (Brown, 2015) .
Our evaluation indicates that the available evidence does not indicate that any of these factors explain the overall lack of an NO 2 effect on AHR for studies involving exercise or exposure to specific airway challenges. In the absence of a biologically plausible explanation for the paradoxical AHR findings, the biological significance of these findings is difficult to interpret.
